Fidelity Select Biotechnology Portfolio (FBIOX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
29.81
-0.07 (-0.23%)
Jul 8, 2026, 4:00 PM EST
Fund Assets5.93B
Expense Ratio0.62%
Min. Investment$0.00
Turnover45.00%
Dividend (ttm)1.62
Dividend Yield5.52%
Dividend Growth611.40%
Payout FrequencySemi-Annual
Ex-Dividend DateApr 10, 2026
Previous Close29.88
YTD Return23.71%
1-Year Return73.61%
5-Year Return53.34%
52-Week Low18.40
52-Week High29.88
Beta (5Y)0.53
Holdings216
Inception DateDec 16, 1985

About FBIOX

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

Fund Family Fidelity
Category Health
Performance Rating Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol FBIOX
Index S&P 500 TR

Performance

FBIOX had a total return of 73.61% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.00%.

Top 10 Holdings

45.11% of assets
NameSymbolWeight
Krystal Biotech, Inc.KRYS10.58%
AbbVie Inc.ABBV9.22%
Amgen Inc.AMGN6.53%
Gilead Sciences, Inc.GILD4.82%
Alnylam Pharmaceuticals, Inc.ALNY2.93%
Praxis Precision Medicines, Inc.PRAX2.47%
Insmed IncorporatedINSM2.25%
argenx SEARGX2.25%
Ascendis Pharma A/SASND2.04%
Revolution Medicines, Inc.RVMD2.02%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Apr 10, 2026$1.063Apr 13, 2026
Dec 12, 2025$0.559Dec 15, 2025
Apr 11, 2025$0.062Apr 14, 2025
Dec 13, 2024$0.166Dec 16, 2024
Apr 12, 2024$0.063Apr 15, 2024
Dec 27, 2023$0.002Dec 28, 2023
Full Dividend History